Welcome to our dedicated page for Ecovyst news (Ticker: $ECVT), a resource for investors and traders seeking the latest updates and insights on Ecovyst stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ecovyst's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ecovyst's position in the market.
Ecovyst Inc. reported first-quarter results for 2024, with sales of $160.5 million and net income of $1.2 million. The company delivered solid results with growth in Ecoservices and Zeolyst Joint Venture. Adjusted EBITDA increased by 6% to $45.5 million. Cash generation was strong, leading to a reduction in net debt leverage ratio to 2.9x. The company provided a positive outlook for 2024, expecting sales of $715-$755 million, Adjusted EBITDA of $255-$275 million, and Free Cash Flow of $85-$105 million.